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Abstract
Background: The role of laparoscopic surgery for the treatment of gastric cancer is still controversial, particularly
in terms of oncologic efficacy. The aim of this study was to compare short-term outcomes of laparoscopic and
open resection for gastric cancer at a single Western institution.
Subjects and Methods: This study was designed as a matched cohort study from a prospective gastric cancer
database. Forty-one patients undergoing laparoscopic gastrectomy for gastric cancer between June 2008 and
January 2012 were matched with 41 patients undergoing open gastrectomy in the same time period. Patient
pairing was done according to age, gender, type of gastrectomy (subtotal or total), and tumor stage via a
randomized statistical method. The short-term outcomes and oncologic adequacy of the laparoscopic and open
procedures were compared. A D2 lymph node dissection was performed in the majority of patients in both
groups.
Results: The two study groups were similar with respect to patient and tumor characteristics. Laparoscopic
procedures were associated with a decreased blood loss (118.7 versus 312.4mL, P < .005), incidence of surgery-
unrelated complications (3 versus 9 patients, P < .05), and duration of hospital stay (8.1 versus 11.5 days, P < .05)
but increased operative time for both subtotal (223.5 versus 158.2 minutes, P < .001) and total (298.1 versus 185.5
minutes, P < .001) gastrectomies. The mean number of retrieved lymph nodes after D2 dissection was similar:
30.0 for laparoscopic and 29.7 for open patients.
Conclusions: Within the limitations of a nonrandomized analysis, this study shows that the laparoscopic
approach is a safe and oncologically adequate option for the treatment of gastric cancer, which compares
favorably with open gastrectomy in short-term outcomes.
Introduction
Laparoscopic surgery has been shown to provideimportant short-term advantages compared with open
surgery for the treatment of several malignant diseaseswith at
least the same long-term survival.1,2 However, the role of
laparoscopic surgery for the treatment of gastric cancer
remains controversial. This is especially true in Western
countries, where the incidence of gastric cancer and, impor-
tantly, of early lesions is much more lower than in the East.3,4
The Western experience of laparoscopic surgery for gastric
cancer is limited to the advanced forms. and only a few
studies comparing laparoscopic and open gastrectomies
are prospective or randomized.5–8 However, all these studies
have clearly shown that the laparoscopic approach can actu-
ally reduce surgical trauma and improve the patient’s quality
of life during the postoperative period compared with the
open procedure.9
Some skepticism still remains regarding the oncological
efficacy of the laparoscopic treatment of gastric cancer, in
particular on the extent of lymphadenectomy.3,10,11 It has been
definitively established that surgical resection with D2 lymph
node dissection is the standard of care and the only potentially
curative treatment available for advanced gastric cancer.12–14
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The concern is to know whether laparoscopy can repro-
duce the same technique as performed in open surgery and
then obtain the same results in terms of lymphadenectomy.
Although several Eastern trials have demonstrated the
oncological safety of laparoscopically assisted distal gastrec-
tomy for early gastric cancer,15–19 there is a need for reliable
evidence to demonstrate comparative oncological results
for advanced tumors, which are more prevalent in Western
series.
The present study was undertaken to compare early sur-
gical results, especially the adequacy of lymphadenectomy,
between the laparoscopic and open approach for subtotal and
total gastrectomy in the treatment of gastric cancer at a single
Western center.
Subjects and Methods
Study design and data collection
Using a prospectively maintained gastric cancer database,
all patients from June 2008 to January 2012 who underwent
curative R0 surgery for gastric adenocarcinoma at the Center
of Oncologic Minimally Invasive Surgery of the University of
Florence, Florence, Italy, were identified. Of these patients, 41
underwent laparoscopic subtotal or total gastrectomies and
were compared with 41 matched patients who underwent
open subtotal or total gastrectomies in the same time period.
Patient pairing was done according to age, gender, type
of gastrectomy (subtotal or total), and tumor stage via a
randomized statistical method. All patients underwent diag-
nostic and preoperative staging work-up according to a
standard protocol, which includes upper digestive endoscopy
with gastric biopsy and computed tomography of the abdo-
men and chest. Patients with distant metastases, para-aortic
lymph node involvement, and/or pre- or intraoperative
diagnosis of T4 lesions (i.e., local invasion of other organs,
including spleen, pancreas, or peritoneum), were excluded
from the study. All patients have been thoroughly informed
about the study and gavewritten consent for the investigation
in accordance with the ethical guidelines of our university.
The characteristics of patients, such as age, gender, body
mass index, history of abdominal surgery, co-morbidities, and
surgical outcomes (operative time, blood loss, postoperative
morbidity and mortality, time-to-first flatus, time-to-first oral
intake, postoperative hospitalization and pathological results)
were examined.
The type of gastric resection, subtotal or total, was deter-
mined according to tumor localization, classified as upper,
middle, and lower third of the stomach. The extension of
lymph node dissection, namely D1+ a/b or D2, was per-
formed according to the lymph node classification of the
Japanese Gastric Cancer Association.20 Tumors were classi-
fied according to the 7th edition of American Joint Committee
on Cancer/TNM tumor staging.21 They were also classified
according to Lauren’s histotype (i.e., intestinal, diffuse, or
mixed).
Surgical technique
Laparoscopic subtotal gastrectomy. Under general
anesthesia, the patient was placed in the supine, reverse
Trendelenburg position with legs abducted. The surgeon
stood between the legs of the patient. Four trocars were used.
One 10–12-mm trocar for the laparoscope was inserted into
the umbilicus. Another 10–12-mm trocar was inserted in the
left midclavicular line 2 cm above the umbilicus as a major
hand port. Two other 5-mm trocars were inserted in the
right midclavicular line 2 cm above the umbilicus and in the
midline just below the xiphoid process. First, a routine
exploration of the abdominal cavity was performed.
The operative strategy involved 11 steps: (1) partial dis-
section of the left greater omentum (until the gastric short
vessels) and the lymph nodes along the left gastroepiploic
vessels (number 4sb); (2) dissection of the right omentum and
the lymph nodes along the right gastroepiploic vessels
(number 4d); (3) exposure of Henle’s trunk and division of the
right gastroepiploic vein and artery for dissection of infra-
pyloric nodes (number 6); (4) transection of the duodenum
just distal to the pyloric ring and reinforcement of the stump
with either interrupted stitches or a barbed running suture
(V-loc; Covidien Ltd., Norwalk, CT); (5) division of the right
gastric artery and dissection of the suprapyloric nodes
(number 5) and the nodes along the proper hepatic artery
(number 12a); (6) dissection of the nodes along the common
hepatic artery (number 8) and the proximal splenic artery
(number 11p); (7) division of the left gastric vein and artery
and dissection of the nodes around these vessels (number 7)
and the celiac trunk (number 9); (8) dissection of the lymph
nodes along the lesser curvature (number 3) and the right
cardiac nodes (number 1); (9) transection of the stomach on
the upper third at least 5 cm above the tumor; (10) mechanical
intracorporeal gastrojejunum anastomosis (either Billroth II or
Roux-en-Y); and (11) mechanical extra- or intracorporeal
jejunum–jejunal anastomosis. Tissue and lymph node dis-
section was performed using an ultrasonic scalpel (Ethicon
Endo-Surgery, Cincinnati, OH). The specimenwas placed in a
polyethylene endobag and pulled out of the peritoneal cavity
through the umbilical port, which was extended to a length of
4–6 cm.
Laparoscopic total gastrectomy. All steps of lymph node
dissection were performed as for subtotal gastrectomy with
the differences of a complete dissection of the left greater
omentum, division of short gastric vessels (number 4a), dis-
section of lymph nodes along the distal splenic artery (number
11d), and dissection of left cardiac lymph nodes (number 2).
The distal esophagus was transected with a linear stapler, and
a Roux-en-Y intracorporeal linear side-to-side esophagojeju-
nal anastomosis was performed in the first five procedures. In
the last 7 patients, we used the newly developed transorally
inserted anvil (OrVil; Covidien) and a circular stapler
(EEA25; Covidien) to perform an intracorporeal circular eso-
phagojejunostomy.22 The specimen was pulled out through
the umbilical port when a linear anastomosis was performed
or through the left subcostal port extended to 4–6 cmwhen the
OrVil device was used. The jejunum–jejunostomy was con-
structed with a linear stapler via these two minilaparotomies.
Open subtotal and total gastrectomy. Open gastrecto-
mies were performed through a median incision. All steps of
lymph node dissection were performed as in the laparoscopic
procedures. Either Billroth II or Roux-en-Y gastrojejunum
anastomoses were used after subtotal gastrectomy, whereas a
Roux-en-Y circular stapling esophagojejunostomy was per-
formed after total gastrectomy.
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Statistical analysis
Matched open cases were randomly selected from the
entire group of curative-intent gastrectomies performed at
our institution during the same period as the laparoscopic
group (LG) via a statistical randomly generated list using
SPSS software package (SPSS, Inc., Chicago, IL). We per-
formed an intention-to-treat analysis to compare short-term
surgical outcomes, such as operative time, estimated blood
loss, time-to-first flatus, time-to-first oral feeding, surgery-
related and unrelated complications, length of stay, tumor
characteristics, surgical margins, and lymph node retrieval.
Categorical variables within the two study groups were
compared using the chi-squared test and Fisher’s exact
test. Quantitative variables were summarized by either
mean – standard error of the mean values or median and
range. Groups were compared using the Mann–Whitney
test. All of the P values resulted from the use of two-sided
statistical tests; P values < .05 were considered statistically
significant.
Results
Patient characteristics
Eighty-two case-matched patients were assessed (41 LG
versus 41 open group [OG]). The LG patients included 24
men (58.5%), and the median age was 73 years (range, 47–87
years). The OG patients included 25 men (61.0%), and the
median age was 74 years (range, 35–90 years). No statistically
significant differences were observed between the two groups
according to age, gender, body mass index, number of prior
abdominal operations, and co-morbidities (Table 1). None of
the patients in the two groups had undergone neoadjuvant
chemotherapy.
Operative outcomes and complications
No LG patients were converted to the open procedure.
Subtotal gastrectomy was performed in 29 patients (70.7%) in
both groups with Billroth II anastomosis in 19 patients and
Roux-en-Y anastomosis in 10 patients in the LG compared
with 16 patients with Billroth II reconstruction and 13 with
Roux-en-Y anastomosis in the OG (Table 2). No statistically
significant differences were found between the two groups
according to these operative characteristics (Table 2). The
extent of lymph node dissection was not statistically different
between the two study groups, with a D2 procedure per-
formed in most patients (37 patients [90.2%] in the LG and 39
[95.1%] in the OG) (Table 2). Mean operative time was
223.5– 8.7 and 298.1– 13.9 minutes for laparoscopic subtotal
and total gastrectomy, respectively. In the OG, mean opera-
tive time was significantly lower than in the LG for both
subtotal and total gastrectomy: 158.2– 9.1 and 185.5– 13.9
minutes, respectively (P< .001) (Table 2). In the OG, the
amount of estimated intraoperative bleeding was more than
in the LG (Table 2).
First flatus and oral feeding took place earlier in the LG
compared with the OG (Table 3). Surgery-related complica-
tions occurred in 6 patients (14.6%) in the LG and in 5 patients
(12.2%) in the OG (Table 3). Complications unrelated to
surgery are shown in Table 3. There were no statistically
significant differences in surgery-related complications be-
tween the two groups, whereas complications unrelated to
surgery were more frequent in the OG than in the LG (Table
3). Re-operation was performed in 3 patients (7.3%) in the LG
(due to focal pancreatitis, duodenal stump leakage, and
stenosis of the jejunum–jejunostomy, respectively) and in 2
patients (4.9%) in theOG (due to duodenal stump leakage and
anastomotic leakage, respectively) (P =not significant). Post-
operative mortality within 30 days was 2.4% (1 patient be-
cause of septic complications after duodenal stump leakage)
in the LG and 4.9% (2 patients, one because of septicTable 1. Demographic Characteristics of Patients
Undergoing Laparoscopic and Open Gastrectomy
Laparoscopic
group
(n = 41)
Open
group
(n= 41)
P
value
Gender (male/female) 24/17 25/16 NS
Age (years) [median
(range)]
73 (47–87) 74 (35–90) NS
BMI (kg/m2)
[median (range)]
26.0 (23–30) 25.0 (19–31) NS
Previous abdominal
surgery (total)
9 (21.9%) 10 (24.3%) NS
Cholecystectomy 5 (12.2%) 3 (7.3%)
Appendicectomy 3 (7.3%) 4 (9.7%)
Hysterectomy 0 (0%) 1 (2.4%)
Anterior resection
of the rectum
1 (2.4%) 0 (0%)
Ovariectomy 0 (0%) 2 (4.9%)
Co-morbidities (total) 13 (31.7%) 12 (29.2%) NS
Hypertension 9 (21.9%) 10 (24.3%)
Diabetes mellitus 4 (9.7%) 3 (7.3%)
Heart diseases 3 (7.3%) 2 (4.9%)
Chronic lung diseases 1 (2.4%) 2 (4.9%)
Liver cirrhosis 1 (2.4%) 0 (0%)
Others 1 (2.4%) 1 (2.4%)
BMI, body mass index; NS, not significant.
Table 2. Comparison of Operative Characteristics
and Outcomes Between the Laparoscopic
and Open Groups
Laparoscopic
group
(n = 41)
Open
group
(n = 41)
P
value
Gastrectomy extent
(subtotal/total)
29/12 29/12 NS
Type of reconstructiona NS
Billroth II 19 (65.5%) 16 (55.2%)
Roux-en-Y 10 (34.5%) 13 (44.8%)
Lymph node dissection NS
D1+ a/b 4 (9.7%) 2 (4.9%)
D2 37 (90.2%) 39 (95.1%)
Mean operative
time (minutes)
Subtotal gastrectomy 223.5– 8.7 158.2– 9.1 < .001
Total gastrectomy 298.1– 13.9 185.5– 13.9 < .001
Blood loss (mL) 118.7– 10.7 312.4– 42.9 < .005
Data are mean– standard error of the mean values or number
(percentage) as indicated.
NS, not significant.
aValid only for subtotal gastrectomy.
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complications after anastomotic leakage and the other be-
cause of cardiac failure) in the OG (P =not significant) (Table
3). Patient hospital length of stay after laparoscopic gastrec-
tomywas 8.1 – 0.5 days, comparedwith 11.5 – 0.8 days among
the open surgery patients (P < .05) (Table 3).
Pathological characteristics
Pathology analyses of all patients were reviewed by one
pathologist (L.M.) skilled in upper gastrointestinal tumors.
There were no significant differences in tumor location, size,
and histotype between the two groups (Table 4). Resection
margins were negative in all LG patients, whereas they were
positive in 1 patient (2.4%) in the OG (Table 4).
There were no significant differences in tumor stage dis-
tribution between the two study groups (Table 4). The overall
mean numbers of lymph nodes retrieved after laparoscopic
and open surgerywere 29.4 – 1.6 and 28.7 – 2.3, respectively. If
only patients with D2 dissection were considered, the mean
number of harvested lymph nodes in the LG patients was
30.0 – 1.5 compared with 29.7 – 2.6 in the OG patients (P =not
significant) (Table 4).
Discussion
Radical surgical resection of the stomach with D2 lymph
node dissection is still the mainstream of the treatment of
advanced gastric cancer.23 Laparoscopic gastrectomy has
been shown to improve short-term results and quality of
life, compared with the open technique, and has become
an acceptable alternative approach in the management of
early gastric cancer, especially in Japan and Korea.24–27 The
development of laparoscopic surgery for gastric cancers in the
Western world has been slower because most gastric cancers
are diagnosed in an advanced stage for which laparoscopic
gastrectomy is not yet considered an acceptable alternative to
standard open surgery.3,4 The skepticism regarding the
oncologic efficacy of laparoscopic gastrectomy is basically
due to its technical complexity and concerns the feasibility of
an oncologically acceptable lymphadenectomy.
The present study confirms the feasibility and safety of the
laparoscopic approach for the treatment of gastric cancer. The
surgery-related complications and mortality rates in our
study were comparable to those of the open approach
and also acceptable if compared with previously published
Western reports.5,8,28–30 One of our major complications was
duodenal stump leakage. We had 2 (4.9%) patients with this
complication, with one death due to septic complications.
However, our incidence of duodenal stump leakage is similar
to that reported by Huscher et al.5 (5%) and Moisan et al.29
(6.5%) but lower than that reported by Orsenigo et al.31
(18.3%). Nowadays, we usually reinforce the duodenal
stump with a running, barbed suture after the duodenal
transaction in an attempt to further reduce the incidence of
this complication.
Our study also confirms the typical advantages of mini-
mally invasive surgery with reduced blood loss, times to
resume oral intake, frequency of surgery-unrelated compli-
cations, and hospital stay in comparison with the open ap-
proach.9,18,19,32 The major operative drawback noted for the
laparoscopic technique was a significantly longer operative
time, in particular for total gastrectomies. However, our op-
erative times are similar to those reported by the majority of
authors who have performed laparoscopic subtotal and total
gastrectomies (ranging from 144 to 348 minutes),8,33,34 and,
to our knowledge, none reported operative times similar to
those of open surgery. Even Taminura et al.35 showed an
average operative time of 248 minutes after 485 laparoscopic
distal gastrectomies, thus emphasizing the demanding
Table 3. Comparison of Postoperative Outcomes
Between the Laparoscopic and Open Groups
Laparoscopic
group
(n = 41)
Open
group
(n = 41)
P
value
Time-to-first flatus (days) 3.0 – 0.3 7.8 – 1.1 < .01
Time-to-first oral
feeding (days)
5.4 – 0.5 9.4 – 0.3 < .05
Surgery-related
complications (total)
6 (14.6%) 5 (12.2%) NS
Focal pancreatitis 2 (4.9%) 0 (0%)
Duodenal stump leakage 2 (4.9%) 2 (4.9%)
Anastomotic leakage 0 (0%) 2 (4.9%)
Anastomotic bleeding 1 (2.4%) 0 (0%)
Gastric stasis 0 (0%) 1 (2.4%)
Anastomotic stenosis 1 (2.4%) 0 (0%)
Surgery-unrelated
complications (total)
3 (7.2%) 9 (21.9%) < .05
Pleural effusion 1 (2.4%) 3 (7.3%)
Pneumonia 0 (%) 2 (4.9%)
Urinary tract infections 1 (2.4%) 2 (4.9%)
Arrhythmia 1 (2.4%) 1 (2.4%)
Deep venous thrombosis 0 (0%) 1 (2.4%)
Re-operations 3 (7.3%) 2 (4.9%) NS
Postoperative mortality 1 (2.4%) 2 (4.9%) NS
Hospital length stay (days) 8.1 – 0.5 11.5 – 0.8 < .05
Data are mean– standard deviation values or number (percent-
age).
NS, not significant.
Table 4. Comparison of Pathological Outcomes
Between the Laparoscopic and Open Groups
Laparoscopic
group
(n = 41)
Open
group
(n = 41)
P
value
Tumor location NS
Upper third 11 (26.8%) 14 (34.1%)
Middle third 12 (29.3%) 10 (24.4%)
Lower third 18 (43.9%) 17 (41.5%)
Tumor size (cm) 5.9 – 0.6 6.1 – 0.8 NS
Lauren’s histotype NS
Intestinal 14 (34.1%) 19 (46.4%)
Diffuse 18 (43.9%) 15 (36.6%)
Mixed 9 (22.0%) 7 (17.0%)
Positive resection margin 0 (0%) 1 (2.4%) NS
Stage distribution (number) NS
Ia/Ib 5/7 4/7
IIa/IIb 7/1 5/2
IIIa/IIIb/IIIc 6/12/3 5/14/4
Number of retrieved
lymph nodes after
D2 dissection
30.0 – 1.5 29.7 – 2.6 NS
Data are mean– standard deviation values or number (percentage)
as indicated.
NS, not significant.
4 CIANCHI ET AL.
technical aspect of this procedure. Nevertheless, it should be
noted that the longer operative time in our experience did
not translate into increased perioperative complications,
whereas the open surgery patients showed more early
surgery-unrelated complications.
The primary end point of the present studywas to ascertain
the oncologic efficacy of laparoscopic gastrectomy and in
particular of laparoscopic D2 lymph node dissection. The
number of lymph nodes needing to be excised is considered
an important factor for patients’ survival following gastric
cancer surgery.23,36 Nevertheless, to date there is no consen-
sus between Eastern (mainly Japan and Korea) and Western
countries regarding to what extent lymphadenectomy should
be performed and, especially, howmany lymph nodes should
be dissected. This controversy stems from the fact that surgery
outcomes in the treatment of gastric cancer are somewhat
better in Asia than in the West in regard to postoperative
morbidity and mortality, number of excised lymph nodes,
and long-term survival.37 It is important that this has been
definitively established for the open surgery and, more re-
cently, has been emerging even for the laparoscopic approach.
As regards lymphadenctomy, the mean number of retrieved
lymph nodes reported by Asian authors after laparoscopic D2
dissection ranges from 23 to 49,18 whereas it ranges from 15 to
35 in Western observational studies.5,7–9,29–31 Our outcomes,
with a mean number of 30.0 examined lymph nodes, are
comparable with these previously reported results and, im-
portantly, are in line with Western criteria (number of lymph
nodes harvested > 25) regarding adequate D2 dissection and
thus surgical quality for advanced gastric cancer.38
In conclusion, within the limitations of a nonrandomized
analysis, our study contributes to the Western experience
by demonstrating both the safety and oncologic efficacy of
the laparoscopic approach to the resection of gastric adeno-
carcinoma. We also confirm that the laparoscopic approach
may provide the benefit of decreased complications and faster
recovery compared with the open technique.
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